d1e30690_dic_NECT___Inclusion_completed__Cancer_type
[Title] Open, single-arm, multicenter, phase II trial investigating the safety of biweekly cabazi-taxel in metastatic castration resistant prostate cancer patients previously treated with docetaxel-containing regimen [Country] FI [Cancer type] 
Prostate cancer
Nordic NECT - Inclusion completed
Cancer type